Concepedia

Alicja Wiercińska‐Drapało

AW

Statistics

Publications

37

Citations

1.4K

H-Index

20

Active since

1999

Affiliations

Medical University of Warsaw(Current)

Medical University of Białystok

The Royal Free Hospital

La Roche College

Medical University of Lodz

Alicja Wiercińska‐Drapało is an author at Medical University of Warsaw specializing in infectious diseases, inflammation, and life sciences.

ORCID

Publications per year

1999–2024

37

Publications

37

The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

Robert Flisiak, Andrzej Horban, Philippe Gallay et al. · Hepatology · 2008 · 223 citations

, , +14

Relationship between current level of immunodeficiency and non‐acquired immunodeficiency syndrome‐defining malignancies

Joanne Reekie, C Kósa, Frederik Neess Engsig et al. · Cancer · 2010 · 140 citations

, , +9

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

Robert Flisiak, Ewa Janczewska, Marta Wawrzynowicz‐Syczewska et al. · Alimentary Pharmacology & Therapeutics · 2016 · 99 citations · Full text

, , +17

Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis

Alicja Wiercińska‐Drapało, Jerzy Jaroszewicz, Ewa Siwak et al. · Regulatory Peptides · 2008 · 94 citations

, , +16

Increased Plasma Transforming Growth Factor- <i>β</i> <sub>1</sub> Is Associated with Disease Progression in HIV-1-Infected Patients

Alicja Wiercińska‐Drapało, Robert Flisiak, Jerzy Jaroszewicz et al. · Viral Immunology · 2004 · 74 citations

, , +8

1–5 of 37